Clinical trial
Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal…
NCT00003368 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003368 |
|---|---|
| Title | Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis |
| Official title | Phase I Study of Irinotecan for Patients With Abnormal Liver or Renal Function or With Prior Pelvic Radiation Therapy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Alliance for Clinical Trials in Oncology |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | irinotecan hydrochloride |
| Start date | Jun 1, 1998 |
| Completion | Jul 1, 2006 |
| First posted | Mar 12, 2004 |
| Last update posted | Mar 21, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: